Jane Street
PLRX icon

Jane Street’s Pliant Therapeutics PLRX Stock Holding History

Jane Street’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29,200
Closed -$777K – 9373
2023
Q1 		$777K Buy
29,200
+16,900
+137% +$481K ﹤0.01% 5503
2022
Q4 		$238K Sell
12,300
-9,200
-43% -$192K ﹤0.01% 7397
2022
Q3 		$449K Buy
+21,500
New +$411K ﹤0.01% 6880

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Jane Street's PLRX Position: Q1 2026 in Review

Jane Street reduced its Pliant Therapeutics (PLRX) stake by 45% in Q1 2026, selling an estimated $375K and leaving 356,794 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #8307.

Jane Street first reported a position in PLRX in Q2 2020 and has held it in 15 quarters since. The position peaked at $5.92M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Jane Street held 356,794 shares of Pliant Therapeutics worth $450K as of Q1 2026.
  • Jane Street sold 296,980 Pliant Therapeutics shares in Q1 2026, an estimated $375K.
  • Pliant Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8307 holding.
  • Jane Street first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 15 quarters since.
  • Jane Street's Pliant Therapeutics position peaked at $5.92M in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.